Skip to main content

Quoin Pharmaceuticals Ltd 8-K, filed Nov 12, 2026

Quoin Pharmaceuticals Ltd. (QNRX)

8-K 2026-11-12 For: 2026-11-12
View Original
Added on November 13, 2026

About this 8-K

Quoin Pharmaceuticals Ltd filed this 8-K on November 12, 2026.

At Quoin Pharmaceuticals Ltd.’s Special General Meeting on November 12, 2026, shareholders approved raising applicable investor ownership limits from 4.99% to as much as 9.99% and authorized an adjournment if needed. AI summary

Items reported

  • Item 5.07: Shareholder vote results